NuDay Rx Tirzepatide Review: Four-Week Price and Care Terms

NuDay Rx’s public Personalized Tirzepatide Compound panel advertises $329 for four weekly subcutaneous injections, including consultation, medication and shipping. It says the same price applies at every dose and no membership is required. If medication is not prescribed, the panel states that the telehealth consultation fee is $80.³

Read the named offer alongside the general FAQ

The named tirzepatide panel provides a more specific offer than the general program-cost FAQ. That FAQ says prices vary by dose and medication, while listing telehealth consultations, a personalized treatment plan, a monthly prescription, shipping, and email and phone support as included. Confirm which terms apply to the actual selected prescription rather than turning the named same-price statement into a permanent price guarantee.³

Four weekly injections are the stated supplied schedule for this product panel. Do not assume that this is an independently confirmed calendar-month renewal interval, an annual price lock or a particular vial quantity. Ask for the actual first charge, next payment date, supplied quantity and any refill authorization before committing.³

A lower starting number may describe a different amount of treatment. The BeyondMD review examines a visible $199 starting figure and a $209 page title without a confirmed supplied period. Obtain the quantity and payment schedule before comparing either figure with four weekly injections.⁵

The site promotes GLP-1 medication alongside video coaching and lifestyle changes. That description does not establish a particular number of coaching appointments, dietitian credentials or unlimited access. Ask who provides support, what is included in the selected plan and whether additional consultations have a separate charge.³

For another program to compare, read the Trinity Meds review. Compare the supplied period, medication, shipping and clinical support separately; a shared ingredient does not make two compounded preparations or service contracts interchangeable.

The $80 fee is not a refund promise

The product panel expressly states that an $80 telehealth consultation fee applies if medication is not prescribed. This is different from a promise of a completely free assessment or an automatic full refund after nonapproval. Obtain the payment authorization and explanation of what will be collected or returned in that situation.³

The patient Terms & Conditions link was unavailable when checked. The public product information does not establish a patient-specific renewal cutoff, medication refund deadline or refund for unused injections. Obtain those terms before payment, including how to stop future refills, when cancellation takes effect and what happens after an order has been sent for dispensing.^3,4

Belmar is named, but confirm the actual dispenser

The pharmacy FAQ reports a partnership with Belmar Pharmacy and provides its contact details. That is more specific than an unnamed-pharmacy statement, but it does not independently establish the particular facility assigned to an individual order, its license status or the exact formulation supplied. Confirm the dispensing pharmacy, prescriber and clinical contact before starting.³

Compounded tirzepatide is not an FDA-approved finished product. Our compounded tirzepatide legal-status guide explains the distinction. Discuss Zepbound side effects, gallbladder risk and the thyroid warning with the prescriber.

SURMOUNT-1 and SURMOUNT-5 concern specific products and protocols, not NuDay Rx’s service or every compounded preparation. The product panel’s advertised trial-outcome percentage is not a demonstrated result for its individual compound.^1,2 Read our tirzepatide evidence guide for context.

Compare the full cost and support

The useful comparison includes the supplied schedule, potential consultation charge, refill conditions and actual clinical support. Read the NextMeds review and provider comparison on those terms. Confirm dietitian access and ongoing fees directly rather than assuming that a competitor’s subscription includes them.